Filing Details

Accession Number:
0001209191-19-018252
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-08 18:15:23
Reporting Period:
2019-03-07
Accepted Time:
2019-03-08 18:15:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080709 Arena Pharmaceuticals Inc ARNA Pharmaceutical Preparations (2834) 232908305
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1302605 Susan Tina Nova 6154 Nancy Ridge Drive
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-07 1,200 $40.10 12,676 No 4 M Direct
Common Stock Disposition 2019-03-07 1,200 $45.99 11,476 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-03-07 1,200 $0.00 1,200 $40.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-03-17 No 4 M Direct
Footnotes
  1. The options vested in twelve equal monthly installments beginning on April 17, 2009, and were immediately exercisable once vested.